Akari Therapeutics Plc (AKTX)
15.68
+0.61
(+4.05%)
USD |
NASDAQ |
Jun 08, 16:00
15.16
-0.52
(-3.32%)
After-Hours: 20:00
Akari Therapeutics Enterprise Value : 15.15M for June 5, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amarin Corp. Plc | -10.19M |
| DBV Technologies SA | 768.94M |
| Cellectis SA | 230.78M |
| Autolus Therapeutics Plc | 545.42M |
| Evaxion AS | 11.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.43M |
| Total Expenses (Quarterly) | 14.43M |
| EPS Diluted (Quarterly) | -9.584 |
| Earnings Yield | -126.3% |